Periodic Reporting for period 1 - Gal3-BrainMets (A novel immunotherapy against brain metastasis: Anti-Galectin-3)

Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. The treatments for this disease are improving patients’ life expectancy. Unfortunately, the increase of free-disease survival also comes with a higher probability for...